Immunosaccharide Technologies Inc.
200 Boston Ave
Ste 200
Medford
MA
02155
United States
(617) 627-3607
Product(s):
Develops emulsan-based drug delivery devices
Ownership:
Private
Immunosaccharide Technologies Inc.
Grant Total (2001-present):
$100,000 Product Submissions:
2005: Emulsan-based Drug Delivery Devices, $100,000
Printer-friendly versionPermalink
Top News Stories
RECENT BLOG POSTS
- Insurers who thought the public plan was a threat have another thing coming
- Now Back to Sales
- Tailoring the message to reach the accountable care organization mandate
- Weekly Wireless Roundup: Psychoanalysis of a nation through Twitter
- Halamka's digest of quality measures for EMR meaningful use
- Seal the deal - or steal it?
- MedGadget's MedTech Monday: Exoskeletons for paraplegics and the battlefield
- How to perform an adhesive lap joint shear strength test: ASTM D1002
- The day before tomorrow
- Now is the time for medical device makers to get on board with accountable care
Navigation
